Gefitinib has been exerted anticancer activities including anti-proliferation, anti-apoptosis, and anti-angiogenesis in several human cancer cell lines with EGFR expression (Ciardiello et al., 2000; Ciardiello and Tortora, 2001; Sirotnak, 2003). Here, EGFR is linked to cancer.